ADRB2 and cancer: Mounting evidence shows that activation of β2-AR signal pathway promotes the carceration, aggression, and metastasis of malignancies, which is related to the progression and treatment resistance of various malignant tumors, including breast cancer, gastric cancer, prostate cancer, and pancreatic cancer [15–19].